Adalimumab Earns FDA Approval for Ulcerative Colitis in Children ...Middle East

Medscape - News
Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older with moderately to severely active ulcerative colitis. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( Adalimumab Earns FDA Approval for Ulcerative Colitis in Children )

Apple Storegoogle play

Also on site :